The integrated Translational Health Research Institute of Virginia

The integrated Translational Research Institute of Virginia today announced its fourth class of iTHRIV Scholars.

The Integrated Translational Health Institute of Virginia, also known as iTHRIV, developed an online tool collecting information related to COVID-19 from volunteers who live in Virginia, according to a news release from UVA Health.

iTHRIV is thrilled to announce that Dr. Tom Hartka's paper examining the accuracy of algorithms in predicting traumatic injury in older adults has been chosen to receive the Best Paper Award from the 2019 Annual Scientific Conference of the AAAM.

Diffusion Pharmaceuticals is currently partnering with the University of Virginia and iTHRIV in a research program to develop its novel small molecule TSC as a treatment for Acute Respiratory Distress Syndrome (ARDS) from COVID-19, specifically targeting the associated multiple organ failure.

 The integrated Translational Health Research Institute of Virginia, or iTHRIV, has awarded pilot funding to four medical research projects.

A study says machine learning algorithms applied to biopsy images can shorten the time for diagnosing and treating a gut disease that often causes permanent physical and cognitive damage in children. For Dr. Sana Syed, an assistant professor of pediatrics in the UVA School of Medicine, this project is an example of why she got into medicine.

Health insurance purchased by state AIDS Drug Assistance Programs for people living with HIV in states that did not expand Medicaid are improving outcomes and have the potential to save millions in healthcare costs, a new study suggests. Researcher Kathleen A. McManus, MD, said increasing enrollment in the plans could help in the effort to end the HIV epidemic.